À propos de ce poste Scientist Immunopeptidomics* chez Immatics
OVERVIEW
We are currently seeking a Scientist Immunopeptidomics* to join our Target Research and Development team in Tuebingen, Germany. Your work will combine experimental immunopeptidomics, quantitative proteomics and data interpretation to characterize HLA-presented targets, advance our platform toward future clinical applications and contribute to our mission of delivering novel PRAME immunotherapies to patients with cancer.
Working closely with laboratory scientists, our mass spectrometry team and colleagues in Data Intelligence, you will develop robust analytical methods and help connect experimental work with reproducible data analysis. This is an opportunity to contribute your scientific expertise and ideas, explore new technologies and shape streamlined, digitally connected workflows that translate research findings into meaningful applications.
This position is offered on a fixed-term contract for 24 months.
YOUR MISSION
Your main responsibilities will include but are not limited to the following tasks:
- Characterize and quantify HLA-presented peptides using Immatics’ proprietary absolute quantitation technology to support therapeutic target validation and the evaluation of biomarkers for patient selection and disease monitoring.
- Develop, optimize and validate immunopeptidomics methodologies using protein biochemistry and mass spectrometry, with a focus on reproducibility, scalability and the analysis of clinically relevant samples.
- Coordinate and manage target characterization activities across departments, aligning experimental plans, timelines and interpretation of results with laboratory, mass spectrometry and Data Intelligence colleagues.
- Establish suitable controls and performance criteria for new workflows, critically evaluate experimental results and document methods and findings to support their transfer into standardized laboratory processes.
- Help develop streamlined, digitally connected workflows and evaluate AI-assisted approaches to data interpretation, documentation and process improvement in collaboration with laboratory and Data Intelligence colleagues.
YOUR PROFILE
You hold a PhD in Life Sciences, Biochemistry, Biotechnology, Medicine, Pharmacy or a related field, ideally complemented by postdoctoral or industry experience. You have expertise in proteomics and/or immunopeptidomics, including protein biochemistry and sample preparation for mass spectrometry.
Experience in translational research, biomarker development, clinical assay validation, DIA-based workflows, clinical cohorts or multi-omics approaches is an advantage.
You are passionate about combining experimental science with data-driven approaches and improving the efficiency and reproducibility of research workflows. Experience with laboratory automation, digital workflows, AI-supported tools, and regulated laboratory processes, including SOPs and method validation, is a plus.
You are motivated to translate scientific discoveries into clinical applications, work independently and analytically, and communicate effectively across multidisciplinary teams. Fluency in written and spoken English is required; German language skills are an advantage.
WHY US?
We are the global leader in precision targeting of PRAME. Driven by our mission to make an impact on the lives of patients with cancer, we are a committed and inspired team and cherish the collegial, highly motivated, and family-friendly atmosphere within Immatics. We offer an innovative and collaborative environment where employees are empowered to contribute to groundbreaking cancer therapies and further their professional growth. To support their well-being, we provide opportunities for continuous learning, a company-sponsored pension scheme, childcare support, and our flexible “Two Out of Three” benefits concept, which allows employees to receive subsidies for two of the following options: EGYM Wellpass, JobRad, and JobTicket.
NOTICE
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
ABOUT IMMATICS
Immatics is committed to making a meaningful impact on the lives of patients with cancer. We are the global leader in precision targeting of PRAME, a target expressed in more than 50 cancers. Our cutting-edge science and robust clinical pipeline form the broadest PRAME franchise with the most PRAME indications and modalities, spanning TCR T-cell therapies and TCR bispecifics.